Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Other Accumulated Expenses (2017 - 2024)

Historic Other Accumulated Expenses for Solesence (SLSN) over the last 12 years, with Q4 2024 value amounting to $1.4 million.

  • Solesence's Other Accumulated Expenses rose 19382.72% to $1.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.4 million, marking a year-over-year increase of 19382.72%. This contributed to the annual value of $1.4 million for FY2024, which is 19382.72% up from last year.
  • Per Solesence's latest filing, its Other Accumulated Expenses stood at $1.4 million for Q4 2024, which was up 19382.72% from $486000.0 recorded in Q4 2023.
  • Over the past 5 years, Solesence's Other Accumulated Expenses peaked at $1.4 million during Q4 2024, and registered a low of $33000.0 during Q4 2021.
  • Over the past 5 years, Solesence's median Other Accumulated Expenses value was $271000.0 (recorded in 2022), while the average stood at $453000.0.
  • As far as peak fluctuations go, Solesence's Other Accumulated Expenses tumbled by 6713.29% in 2020, and later skyrocketed by 72121.21% in 2022.
  • Over the past 5 years, Solesence's Other Accumulated Expenses (Quarter) stood at $47000.0 in 2020, then decreased by 29.79% to $33000.0 in 2021, then soared by 721.21% to $271000.0 in 2022, then skyrocketed by 79.34% to $486000.0 in 2023, then skyrocketed by 193.83% to $1.4 million in 2024.
  • Its last three reported values are $1.4 million in Q4 2024, $486000.0 for Q4 2023, and $271000.0 during Q4 2022.